Eli Lilly and Compan

LLY
Delayed Nyse - 07/19 10:01:32 pm
106.79USD
-1.43%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (47.6%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (17.4%);
- veterinary medicine (12.8%);
- cardiovascular diseases (9.2%);
- neurology (7.4%): primarily drugs used in treating depression and schizophrenia;
- immunology diseases (4.6%);
- other (1%).
Net sales are distributed geographically as follows: the United States (56.5%), Europe (17.2%), Japan (10.2%) and other (16.1%).
Sales per Businesses
20162017
USD
(in Million)
%USD
(in Million)
%
Human Pharmaceutical Products18,06485.1%19,78686.5%
Animal Health3,15814.9%3,08613.5%
Sales per Regions
20162017
USD
(in Million)
%USD
(in Million)
%
United States11,50654.2%12,78555.9%
Europe3,76817.8%3,94317.2%
Other Foreign Countries3,61717%3,72316.3%
Japan2,33111%2,42010.6%
Managers
Name Title
David A. Ricks Chairman, President & Chief Executive Officer
Thomas F. Bumol Senior VP-Biotechnology & Autoimmunity Research
Timothy J. Garnett Chief Medical Officer & VP-Global Medical
Michael R. Meadows VP & Chief Technology Officer
Aarti Shah Chief Information Officer & SVP-IT
Daniel M. Skovronsky Chief Scientific Officer & Senior Vice President
Kathi P. Seifert Independent Director
Ellen R. Marram Lead Independent Director
Jon Erik Fyrwald Independent Director
Michael L. Eskew Independent Director
Shareholders
Name Equities %
Lilly Endowment, Inc. 117,825,304 11.1%
The Vanguard Group, Inc. 72,671,088 6.86%
Wellington Management Co. LLP 53,603,659 5.06%
PRIMECAP Management Co. 51,415,046 4.85%
BlackRock Fund Advisors 46,438,189 4.38%
SSgA Funds Management, Inc. 40,014,611 3.78%
Dodge & Cox 22,692,971 2.14%
State Farm Investment Management Corp. 19,944,525 1.88%
Franklin Mutual Advisers LLC 14,418,407 1.36%
Geode Capital Management LLC 12,277,313 1.16%
Company contact information
Lilly Corporate Center
IN 46285 Indianapolis, Indiana
États-Unis (les)

Phone : +1 617-225-3226
Fax : +1
Internet : https://investor.lilly.com/
Markets and indexes
- NYSE
- Main Market
- SP 100 / SP 500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  LLY:US
- Reuters Code :  LLY.N
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
ELI LILLY AND COMPANY-6.38%98 336
JOHNSON & JOHNSON2.34%345 980
PFIZER-1.35%237 451
ROCHE HOLDING LTD.11.42%230 263
ROCHE HOLDING13.37%230 263
NOVARTIS24.46%216 273
MERCK AND COMPANY6.52%209 550
NOVO NORDISK AS8.16%113 722
AMGEN-7.77%108 806
ASTRAZENECA8.80%104 798
SANOFI-1.44%104 587
GLAXOSMITHKLINE10.41%101 836
ABBVIE-25.65%101 327
BRISTOL-MYERS SQUIBB COMPANY-15.26%70 876
CELGENE CORPORATION41.85%63 614
BAYER AG-1.67%62 271
TAKEDA PHARMACEUTICAL CO LTD3.48%54 460
ALLERGAN PLC21.24%53 488
MERCK KGAA(ADR)0.67%45 566
JIANGSU HENGRUI MEDICINE CO.25.16%42 445
DAIICHI SANKYO COMPANY, LIMITED88.50%38 828
Brand Portfolio
ARMO BIOSCIENCES
ARMO BIOSCIENCES
CHEMGEN
CHEMGEN
ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
IMCLONE SYSTEMS
IMCLONE SYSTEMS
LOXO ONCOLOGY
LOXO ONCOLOGY
PHARMASERVE-LILLY
PHARMASERVE-LILLY
» More brands of Eli Lilly And Company